Measurement and modeling of stimulus-evoked electromyography in lengthened and shortened muscles for spinal cord injured subjects during an electrically-elicited fatigue process

Evoked EMG and muscle fatigue during isokinetic FES-cycling in individuals with SCI

PURPOSE

This study investigated whether muscle fatigue during functional electrical stimulation (FES)-induced cycling was associated with changes occurring in evoked electromyographic signals (eEMG, M-waves) in individuals with spinal cord injury. We also explored the effects of recovery intervals between exercise sessions on the relationship between eEMG and muscle torque.

METHODS

Eight individuals with spinal cord injury performed three FES-cycling sessions of 15-min duration, with 5 min of recovery between them. The quadriceps muscles were electrically stimulated as the prime agonist to produce cycling. Pedal torques and surface eEMG signals were synchronously processed and recorded for offline analysis.

RESULTS

Large Torque decreases (20-44%) were observed in the first 5 min of cycling during the three exercise bouts, while changes of similar magnitude did not occur on any of the M-wave time-series (less than 19%). Between 5 and 15 min of cycling, muscle fatigue lowered the plateau baselines of Torque (ranging from 41% to 62%), M-wave peak-to-peak amplitude (PtpA) and Area (ranging from 60% to 98%) time-series, yet the magnitudes of these reductions were not consistent between them.

CONCLUSION

We concluded that muscle fatigue during FES-cycling was not associated with, nor could be predicted by, eEMG signals. Nonetheless, the consistency between M-waves and Torque time-curves in their direction of change clearly warrants further investigation.

Cloning, expression, and functional analysis of rhesus monkey trace amine-associated receptor 6: evidence for lack of monoaminergic association

Several recent studies report an association between trace amine-associated receptor 6 (TAAR6) and susceptibility to schizophrenia and bipolar affective disorder in humans. However, endogenous TAAR6 agonists and the receptor signaling profile and brain distribution remain unclear. Here, we clone TAAR6 from the rhesus monkey and use transfected cells to investigate whether this receptor interacts with brain monoamines and a psychostimulant drug to trigger cAMP signaling or extracellular signal-regulated kinase (ERK) phosphorylation, while investigating its expression profile in the rhesus monkey brain. Unlike TAAR1, rhesus monkey TAAR6 did not alter cAMP levels in response to 10 microM of monoamines (dopamine, norepinephrine, serotonin, beta-phenylethylamine (beta-PEA), octopamine, tryptamine, and tyramine) or methamphetamine in stably transfected cells in vitro. Real-time cell electronic sensing analysis indicated that the receptor did not alter cell impedance or change the effect of forskolin on cell impedance at exposure to 20 microM of each monoamine, suggesting a lack of either Gs or Gi-linked signaling. Whereas kappa opioid receptor activation led to ERK phosphorylation at exposure to 1 microM U69593, rhesus monkey TAAR6 had no such effect at exposure to 10 microM of monoamines or methamphetamine. Membrane and cell surface localization of TAAR6 was confirmed by immunocytochemistry, biotinylation, and Western blot testing with a TAAR6 antibody in the transfected cells. Real-time reverse transcriptase-polymerase chain reaction amplification showed that TAAR6 mRNA was undetectable in selected rhesus monkey brain regions. Together, the data reveal that TAAR6 is unresponsive to brain monoamines and is not expressed in rhesus monkey brain monoaminergic nuclei, suggesting TAAR6 lacks direct association with brain monoaminergic neuronal function.